Survival in Patients with Brain Metastases Treated with Whole Brain Radiotherapy at the Instituto Nacional de Cancerología

Authors

  • Rosalba Ospino Instituto Nacional de Cancerología
  • Ricardo Cendales Instituto Nacional de Cancerología
  • Jaime Triana Instituto Nacional de Cancerología

Keywords:

Survival analysis, neoplasm metastasis, central nervous system, radiotherapy, follow-up studies, Colombia

Abstract

Objective: To describe the overall survival among patients with brain metastases treated with whole brain radiation therapy at the Instituto Nacional de Cancerología (INC) during 2004-2006.
Methods: A survival study was conducted. All patients with brain metastases treated with whole brain radiotherapy were included. Frequencies, central tendency, and dispersion measures were used to describe discrete and continuous variables. Survival analysis was performed by the Kaplan-Meyer method.
Results: 109 patients were included and the vital status was updated in 85 patients (80%). The median follow-up time was 2.76 months. 78 deaths were observed; the median survival time was 5.2 months and the cumulated one-year overall survival 25.5%. Karnofsky index, extra-cranial metastases, type of lesion, and recursive partitioning analysis (RPA) were significant prognostic factors. The overall median survival for recursive partitioning analysis class I was 7.2 months; class II 6.9 months; class III 1.8 months.
Conclusion: Overall survival INC are similar than previous international series for RPA class I and III, while it was better in RPA class II.

Author Biographies

Rosalba Ospino, Instituto Nacional de Cancerología

Grupo de Radioterapia, Instituto Nacional de Cancerología, Bogotá, Colombia.

Ricardo Cendales, Instituto Nacional de Cancerología

Grupo de Radioterapia, Instituto Nacional de Cancerología, Bogotá, Colombia.

Jaime Triana, Instituto Nacional de Cancerología

Grupo de Radioterapia, Instituto Nacional de Cancerología, Bogotá, Colombia.

References

Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol. 1988;45(7):741-4.

https://doi.org/10.1001/archneur.1988.00520310047016

Norden A, Wen PY, Kesari S. Brain metastases. Curr Opin Neurol. 2005;18(6):654-61.

Graus F, Walker RW, Allen JC. Brain metastases in children. J Pediatr. 1983;103(4):558-61.

https://doi.org/10.1016/S0022-3476(83)80583-6

Mehta MP, Rodrigus P, Terhaard CH, Rao A, Suh J, Roa W, et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol. 2003;21(13):2529-36.

https://doi.org/10.1200/JCO.2003.12.122

Broadbent AM, Hruby G, Tin MM, Jackson M, Firth I. Survival following whole brain radiation treatment for cerebral metastases: an audit of 474 patients. Radiother Oncol. 2004;71(3):259-65.

https://doi.org/10.1016/j.radonc.2004.02.019

Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998;280(17):1485-9.

https://doi.org/10.1001/jama.280.17.1485

Patchell RA. The management of brain metastases. Cancer Treat Rev. 2003;29(6):533-40.

https://doi.org/10.1016/S0305-7372(03)00105-1

Bradley KA, Metah MP. Management of brain metastases. Semin Oncol. 2004;31(5):693-701.

https://doi.org/10.1053/j.seminoncol.2004.07.012

Mehta MP, Tsao MN, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2005;63(1):37-46.

https://doi.org/10.1016/j.ijrobp.2005.05.023

Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37(4):745-51.

https://doi.org/10.1016/S0360-3016(96)00619-0

Gaspar LE, Scott C, Murray K, Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys. 2000;47(4):1001-6.

https://doi.org/10.1016/S0360-3016(00)00547-2

Weltman E, Salvajoli JV, Brandt RA, de Morais Hanriot R, Prisco FE, Cruz JC, et al. Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys. 2000;46(5):1155-61.

https://doi.org/10.1016/S0360-3016(99)00549-0

Lorenzoni J, Devriendt D, Massager N, David P, Ruiz S, Vanderlinden B, et al. Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys. 2004;60(1):218-24.

https://doi.org/10.1016/j.ijrobp.2004.02.017

Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 2008;70(2):510-4.

https://doi.org/10.1016/j.ijrobp.2007.06.074

How to Cite

[1]
Ospino, R. et al. 2010. Survival in Patients with Brain Metastases Treated with Whole Brain Radiotherapy at the Instituto Nacional de Cancerología. Revista Colombiana de Cancerología. 14, 1 (Mar. 2010), 29–36.

Downloads

Download data is not yet available.

Issue

Section

Research/original articles